{"altmetric_id":4354128,"counts":{"readers":{"mendeley":14,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["TumorImm_papers"],"posts_count":1}},"selected_quotes":[".@LeCrist81 Lung cancer vaccines: No miracle cure (yet), but one of many emerging immunother\u2026",".@LeCrist81 Lung cancer vaccines: No miracle cure (yet), but one of many emerging immunotherapy options."],"citation":{"altmetric_jid":"4f6fa61b3cf058f61000772f","authors":["Domingues D","Turner A","Silva MD","Marques DS","Mellidez JC","Wannesson L","Mountzios G","de Mello RA"],"doi":"10.2217\/imt.14.82","first_seen_on":"2015-08-02T06:45:02+00:00","issns":["1750-743X"],"issue":"11","journal":"Immunotherapy","last_mentioned_on":1438497693,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25496336?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25496336"],"pmid":"25496336","pubdate":"2014-11-15T00:00:00+00:00","subjects":["allergyandimmunology"],"title":"Immunotherapy and lung cancer: current developments and novel targeted therapies.","type":"article","volume":"6","mendeley_url":"http:\/\/www.mendeley.com\/research\/immunotherapy-lung-cancer-current-developments-novel-targeted-therapies-4"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":5428000,"mean":6.3206828302661,"rank":4516400,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":5428000,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":190061,"mean":8.8169268757235,"rank":152278,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":190061,"percentile":1},"this_journal":{"total_number_of_other_articles":349,"mean":2.8338735632184,"rank":293,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":349,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":27,"mean":2.3753846153846,"rank":22,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":27,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":1,"Researcher":2,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":2,"Student  > Postgraduate":2,"Student  > Master":1,"Other":1,"Student  > Bachelor":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":6,"Immunology and Microbiology":2,"Agricultural and Biological Sciences":3,"Unspecified":3}}},"geo":{"mendeley":{"US":1,"PL":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/TumorImm_papers\/status\/627730939737583616","license":"datasift","citation_ids":[4354128],"posted_on":"2015-08-02T06:41:33+00:00","author":{"name":"TumorImmunoPapers","image":"https:\/\/pbs.twimg.com\/profile_images\/741322452093931520\/rQvFtFTA_normal.jpg","description":"A TwitterBot for Cancer Immunology and Tolerance papers on #PubMed. Curated by @adamsnookphd","id_on_source":"TumorImm_papers","tweeter_id":"2829712275","geo":{"lt":null,"ln":null},"followers":660},"tweet_id":"627730939737583616"}]}}